pennews
www.pennews.net
IOL successfully completes USFDA inspection
Business

IOL successfully completes USFDA inspection

Agency News

Mumbai, Oct 26 : The IOL Chemicals and Pharmaceuticals said here on Saturday that it has received a communication from the US Food and Drug Administration (FDA) with respect to an inspection conducted by the USFDA of Ibuprofen manufacturing facilities located at Trident Complex, Mansa Road in Barnala of Punjab.

The inspection was carried out between August 5 to 9, 2019.

The FDA has concluded that inspection is 'closed' under 21 CFR part 20.64(d)(3), the company said in a filing with BSE.
(UNI)